The number of photopheresis centers in the United States is expanding rapidly.
Today, more than 150 centers have been established in leading medical institutions across the country. Only those treatment centers that have authorized Therakos, Inc. to print their contact information are listed.
THERAKOS™ Photopheresis is provided by prescription only. You will require a referral from your healthcare provider to receive treatment. This information is only offered for your convenience.
Enter your zip code or city and state to locate the treatment center nearest you.
Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.
THERAKOS™ Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.